Lamotrigin BMM Pharma 200 mg Tablett

국가: 스웨덴

언어: 스웨덴어

출처: Läkemedelsverket (Medical Products Agency)

제품 특성 요약 제품 특성 요약 (SPC)
08-12-2020

유효 성분:

lamotrigin

제공처:

Ebb Medical AB

ATC 코드:

N03AX09

INN (International Name):

lamotrigine

복용량:

200 mg

약제 형태:

Tablett

구성:

lamotrigin 200 mg Aktiv substans; laktosmonohydrat Hjälpämne

수업:

Apotek

처방전 유형:

Receptbelagt

치료 영역:

Lamotrigin

승인 상태:

Avregistrerad

승인 날짜:

2015-02-11

제품 특성 요약

                                1
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Lamotrigin Bluefish 25 mg tablet
Lamotrigin Bluefish 50 mg tablet
Lamotrigin Bluefish 100 mg tablet
Lamotrigin Bluefish 200 mg tablet
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet Lamotrigin Bluefish 25 mg contains 25 mg lamotrigine.
Each tablet Lamotrigin Bluefish 50 mg contains 50 mg lamotrigine.
Each tablet Lamotrigin Bluefish 100 mg contains 100 mg lamotrigine.
Each tablet Lamotrigin Bluefish 200 mg contains 200 mg lamotrigine.
Excipient(s) with known effect:
Each tablet Lamotrigin Bluefish 25 mg contains 52.50 mg lactose
monohydrate
Each tablet Lamotrigin Bluefish 50 mg contains 105 mg lactose
monohydrate
Each tablet Lamotrigin Bluefish 100 mg contains 210 mg lactose
monohydrate
Each tablet Lamotrigin Bluefish 200 mg contains 420 mg lactose
monohydrate
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet.
Lamotrigin Bluefish 25 mg tablets are yellow, round tablets marked
“25” on one side and with a score
line on the other. Size: 6 mm.
Lamotrigin Bluefish 50 mg tablets are yellow, round tablets marked
“50” on one side and with a score
line on the other. Size: 8 mm.
Lamotrigin Bluefish 100 mg tablets are yellow, round tablets marked
“100” on one side and with a
score line on the other. Size: 10 mm.
Lamotrigin Bluefish 200 mg tablets are yellow, capsule shaped,
biconvex tablets marked “200” on one
side. Size: 8x18 mm.
The score line is only to facilitate breaking for ease of swallowing
and not to divide into equal doses.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Epilepsy
_Adults and adolescents aged 13 years and above_
Adjunctive or monotherapy treatment of partial seizures and
generalised seizures, including tonic-
clonic seizures.
Seizures associated with Lennox-Gastaut syndrome. Lamotrigin Bluefish
is given as adjunctive
therapy but may be the initial antiepileptic drug (AED) to start with
in Lennox-Gastaut syndrome.
_Children and adolescents aged 2 to 12 years_
Adjunctive tr
                                
                                전체 문서 읽기
                                
                            

다른 언어로 된 문서

환자 정보 전단 환자 정보 전단 영어 13-12-2023
제품 특성 요약 제품 특성 요약 영어 13-12-2023
공공 평가 보고서 공공 평가 보고서 영어 04-02-2013